Company

Cabaletta Bio ($CABA)

  • Biotech
Founded:
2017

Overview

Develops engineered T cell therapies for autoimmune diseases, including rese-cel in Phase 1/2 trials for lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris.